Impact of in Vitro Driven Expression Signatures of CD133 Stem Cell Marker and Tumor Stroma on Clinical Outcomes in Gastric Cancers

BMC Cancer - United Kingdom
doi 10.1186/s12885-019-5332-y
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

CD133 in Breast Cancer Cells: More Than a Stem Cell Marker

Journal of Oncology
Oncology
2019English

Embryonic Stem Cell Markers Expression in Cancers

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2009English

STAT3 Is a Key Transcriptional Regulator of Cancer Stem Cell Marker CD133 in HCC

HepatoBiliary Surgery and Nutrition
2016English

The Stem Cell Marker CD133 Associates With Enhanced Colony Formation and Cell Motility in Colorectal Cancer

PLoS ONE
Multidisciplinary
2010English

Rapid Re-Expression of CD133 Protein in Colorectal Cancer Cell Lines in Vitro and in Vivo

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2012English

Expression of Snail Protein in Tumor–stroma Interface

Oncogene
Cancer ResearchGeneticsMolecular Biology
2006English

Study of Stem Cell Marker Proteins in Atypical Teratoid Rhabd Tumor

Biomarkers and Applications
2018English

Deleterious Effects of KIR Ligand Incompatibility on Clinical Outcomes in Haploidentical Hematopoietic Stem Cell Transplantation Without in Vitro T-Cell Depletion

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Identification of Stem-Like Cells and Clinical Significance of Candidate Stem Cell Markers in Gastric Cancer

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy